Conformational Analysis of the Androgen Receptor Amino-terminal Domain Involved in Transactivation
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 56 of the 56 references it cites were found in a registry or an index.
Abstract
The androgen receptor (AR) is a member of the nuclear receptor superfamily. Sequences within the large amino-terminal domain of the receptor have been shown to be important for transactivation and protein-protein interactions; however, little is known about the structure and folding of this region. In the present study we show that a 344-amino acid polypeptide representing the main determinants for transactivation has the propensity to form alpha-helical structure and that mutations which disrupt putative helical regions alter conformation. Folding of the AR was observed in the presence of the helix-stabilizing solvent trifluoroethanol and the natural osmolyte trimethylamine N-oxide (TMAO). TMAO resulted in the movement of two tryptophan residues to a less solvent-exposed environment and the formation of secondary/tertiary structure resistant to protease cleavage. Critically, binding to the RAP74 subunit of the general transcription factor TFIIF resulted in extensive protease resistance, consistent with induced folding of the receptor transactivation domain. These data indicate that this region of the AR is structurally flexible and folds into a stable conformation upon interactions with a component of the general transcription machinery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interaction of the NTD with its coactivator binding partners stabilizes the NTD structure and converts the NTD into a protease-resistant conformation (Kumar et al., 2004; Lavery and McEwan, 2008b; Reid et al., 2002).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Reid et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biochemical and computational analyses suggest that the AR NTD contains intrinsically disordered regions and the isolated NTD exists as a “collapsed” disordered or molten globule-like structure, which represents an intermediate state between a folded globule structure and an unfolded random-coil structure (Lavery and McEwan, 2008b; Reid et al., 2002).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Reid et al., 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm
Wright, P. E., & Dyson, H. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3110 · Cited by 2,968
A Self-Consistent Method for the Analysis of Protein Secondary Structure from Circular Dichroism
Sreerama, N., & Woody, R. W. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1079 · Cited by 1,045
Eftink, M. R., & Ghiron, C. A. (1976) · Biochemistry · doi:10.1021/bi00648a035 · Cited by 1,034
Radhakrishnan, I., Pérez-Alvarado, G. C., Parker, D., Dyson, H. J., Montminy, M. R., & Wright, P. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80463-8 · Cited by 728
Transcriptional activation and nuclear targeting signals of the human androgen receptor.
Simental, J. A., Sar, M., Lane, M. V., French, F. S., & Wilson, E. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52466-2 · Cited by 631
Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004571200 · Cited by 608
Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., & Brinkmann, A. O. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1396 · Cited by 523
He, B., Kemppainen, J. A., & Wilson, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002807200 · Cited by 442
The structure of the nuclear hormone receptors
Kumar, R., & Thompson, E. B. (1999) · Steroids · doi:10.1016/s0039-128x(99)00014-8 · Cited by 435
Research works printed but not linked: 2
- Berrevoets, 1998, Mol. Endocrinol., 12, 1172, 10.1210/mend.12.8.0153 · doi:10.1210/mend.12.8.0153 · Paper page
- Tan, 2000, Endocrinology., 141, 3440, 10.1210/endo.141.9.7680 · doi:10.1210/endo.141.9.7680 · Paper page
Cited by
Androgen receptor: structure, role in prostate cancer and drug discovery
Tan, M. E., Li, J., Xu, H. E., Melcher, K., & Yong, E.-L. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.18 · Cited by 943
Andersen, R. J., Mawji, N. R., Wang, J., Wang, G., Haile, S., Myung, J.-K., Watt, K., Tam, T., Yang, Y. C., Bañuelos, C. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.027 · Cited by 503
Self-citationNuclear Receptor Structure: Implications for Function
Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D., & Miura, M. T. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160308 · Cited by 366
Wärnmark, A., Treuter, E., Wright, A. P. H., & Gustafsson, J.-A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0384 · Cited by 308
“Similar to what has been shown for other NRs, the AF-1 domain of AR possesses limited secondary structure in aqueous solution and has been demonstrated to acquire a more folded conformation upon binding to a coregulator protein (86).”
MethodAn androgen receptor N-terminal domain antagonist for treating prostate cancer
Myung, J.-K., Banuelos, C. A., Fernandez, J. G., Mawji, N. R., Wang, J., Tien, A. H., Yang, Y. C., Tavakoli, I., Haile, S., Watt, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66398 · Cited by 305
“The steady-state fluorescence spectrum of AF1 denatured by urea showed a distinct peak for tyrosine and red shift for tryptophan (i.e., 343 nm to 350 nm), indicative of the tryptophan becoming more solvent exposed and the polypeptide being unstructured (28).”
InfluentialSelf-citationMahajan, N. P., Liu, Y., Majumder, S., Warren, M. R., Parker, C. E., Mohler, J. L., Earp, H. S., & Whang, Y. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700420104 · Cited by 274
Gene regulation by the glucocorticoid receptor: structure:function relationship
Kumar, R., & Thompson, E. B. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.046 · Cited by 261
Zhu, P., Baek, S. H., Bourk, E. M., Ohgi, K. A., Garcia-Bassets, I., Sanjo, H., Akira, S., Kotol, P. F., Glass, C. K., Rosenfeld, M. G., et al. (2006) · Cell · doi:10.1016/j.cell.2005.12.032 · Cited by 259
“These residues are predicted to form a specific putative helical structure (Reid et al., 2002).”
The Dynamic Structure of the Estrogen Receptor
Kumar, R., Zakharov, M. N., Khan, S. H., Miki, R., Jang, H., Toraldo, G., Singh, R., Bhasin, S., & Jasuja, R. (2011) · Journal of Amino Acids · doi:10.4061/2011/812540 · Cited by 252
Chmelar, R., Buchanan, G., Need, E. F., Tilley, W., & Greenberg, N. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22365 · Cited by 255
“act directly with members of the transcription machinery, including components of the RNA polymerase II complex(107) and TFIIF,(101) the latter promoting conformational changes in the AR-NTD.(149)”
BackgroundLavery, D. N., & Mcewan, I. J. (2005) · Biochemical Journal · doi:10.1042/bj20050872 · Cited by 227
Self-citationStructural and functional consequences of glutamine tract variation in the androgen receptor
Buchanan, G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh181 · Cited by 225
“As it has been recently demonstrated that structural order within the AR-NTD is correlated with recruitment of the transcription machinery and receptor activity (57,58), we sought to assess whether the polyQ2L mutation alters AR-NTD structure.”
BackgroundInfluentialKumar, R., & Thompson, E. B. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0258 · Cited by 210
Mutation of the androgen receptor causes oncogenic transformation of the prostate.
Han, G., Buchanan, G., Ittmann, M., Harris, J. M., Yu, X., DeMayo, F. J., Tilley, W., & Greenberg, N. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408925102 · Cited by 192
Targeting androgen receptor phase separation to overcome antiandrogen resistance
Xie, J., He, H., Kong, W., Li, Z., Gao, Z., Xie, D., Sun, L., Fan, X., Jiang, X., Zheng, Q., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01151-y · Cited by 166
Role of naturally occurring osmolytes in protein folding and stability
Kumar, R. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.09.007 · Cited by 160
McEwan, I. J. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110281 · Cited by 156
“TFIIF is a heterotetramer of RAP30 and RAP74 subunits, and binding sites for the receptor have been mapped to the N-and C-terminal globular domains of the large subunit (Reid et al. 2002 b ).”
BackgroundResultInfluentialSelf-citationStructural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes
Yu, X., Yi, P., Hamilton, R. A., Shen, H., Chen, M., Foulds, C. E., Mancini, M. A., Ludtke, S. J., Wang, Z., & O’Malley, B. W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.031 · Cited by 154
Naturally occurring organic osmolytes: From cell physiology to disease prevention
Khan, S. H., Ahmad, N., Ahmad, F., & Kumar, R. (2010) · IUBMB Life · doi:10.1002/iub.406 · Cited by 151
“Further, proteolytic digestion and fluorescence emission experiments suggest the formation of tertiary structure in these peptides (30, 31).”
BackgroundResultDe Mol, E., Fenwick, R. B., Phang, C. T. W., Buzón, V., Szulc, E., de la Fuente, A., Escobedo, A., García, J., Bertoncini, C. W., Estébanez-Perpiñá, E., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00182 · Cited by 147
Self-citationEukaryotic transcription factors: paradigms of protein intrinsic disorder
Staby, L., O'Shea, C., Willemoës, M., Theisen, F., Kragelund, B. B., & Skriver, K. (2017) · Biochemical Journal · doi:10.1042/bcj20160631 · Cited by 139
Allosteric Modulators of Steroid Hormone Receptors: Structural Dynamics and Gene Regulation
Kumar, R., & McEwan, I. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1033 · Cited by 135
Self-citationHe, B., Bai, S., Hnat, A. T., Kalman, R. I., Minges, J. T., Patterson, C., & Wilson, E. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403117200 · Cited by 136
Intrinsic disorder in cell signaling and gene transcription
Tantos, Á., Han, K., & Tompa, P. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.015 · Cited by 122
Interplay between two hormone-independent activation domains in the androgen receptor.
Callewaert, L., Van Tilborgh, N., & Claessens, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2389 · Cited by 111
Tung, L., Abdel-Hafiz, H., Shen, T., Harvell, D. M. E., Nitao, L. K., Richer, J. K., Sartorius, C. A., Takimoto, G. S., & Horwitz, K. B. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0105 · Cited by 96
Structural and functional analysis of domains of the progesterone receptor
Hill, K. K., Roemer, S. C., Churchill, M. E. A., & Edwards, D. P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.017 · Cited by 96
“NTDs of GR, ER and AR have been shown to undergo folding coupled with binding of TBP, CBP, or the RAP74 subunit of TFIIF, in a manner that results in greater a helical content of the NTD (Kumar et al., 2004a,b; Lavery and McEwan, 2006; Reid et al., 2002; Warnmark et al., 2001).”
BackgroundZhu, J., Salvatella, X., & Robustelli, P. (2022) · Nature Communications · doi:10.1038/s41467-022-34077-z · Cited by 97
Lavery, D. N., & McEwan, I. J. (2008) · Biochemistry · doi:10.1021/bi702221e · Cited by 93
Self-citationAndrogen receptor gene mutation, rearrangement, polymorphism.
Eisermann, K., Wang, D., Jing, Y., Pascal, L. E., & Wang, Z. (2013) · PubMed Central · doi:10.3978/j.issn.2223-4683.2013.09.15 · Cited by 122
“This distinguishes AR from the other steroid receptors that primarily utilize the AF2 region in the LBD (11).”
BackgroundMinireview: Dynamic Structures of Nuclear Hormone Receptors: New Promises and Challenges
Simons, S. S., Edwards, D. P., & Kumar, R. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1334 · Cited by 88
“Other unrelated proteins have also been reported to bind and induce folding of the NTD/AF1s of SHRs including transcription factor IIF, CREB-binding protein, receptor-interacting protein 140 and silencing mediator of retinoid and thyroid hormone receptor (16, 20, 24, 25, 32, 36).”
BackgroundIntrinsic disorder in the androgen receptor: identification, characterisation and drugability
McEwan, I. J. (2011) · Molecular BioSystems · doi:10.1039/c1mb05249g · Cited by 86
Self-citationTATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain
Kumar, R., Volk, D. E., Li, J., Lee, J. C., Gorenstein, D. G., & Thompson, E. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407160101 · Cited by 86
Structural Dynamics, Intrinsic Disorder, and Allostery in Nuclear Receptors as Transcription Factors
Hilser, V. J., & Thompson, E. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.278929 · Cited by 91
McEwan, I. J., Lavery, D., Fischer, K., & Watt, K. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05001 · Cited by 81
Self-citationPonnusamy, S., He, Y., Hwang, D., Thiyagarajan, T., Houtman, R., Bocharova, V., Sumpter, B. G., Fernandez, E. J., Johnson, D. L., Du, Z., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1458 · Cited by 83
“The folding or unfolding of AR-AF1/NTD has been investigated using TMAO, which has been shown to facilitate the folding of proteins into "native" conformations (56).”
BackgroundMethodSelf-citationDiscovery of drugs that directly target the intrinsically disordered region of the androgen receptor
Sadar, M. D. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1732920 · Cited by 76
Compatible solutes as protectants for zymogens against proteolysis
Kolp, S., Pietsch, M., Galinski, E. A., & Gütschow, M. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.04.015 · Cited by 88
Takimoto, G. S., Tung, L. W., Abdel-Hafiz, H. A., Abel, M. G., Sartorius, C. A., Richer, J. K., Jacobsen, B. M., Bain, D. L., & Horwitz, K. B. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00197-3 · Cited by 88
Fischer, K., Kelly, S. M., Watt, K., Price, N. C., & McEwan, I. J. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0005 · Cited by 71
“An induced folding mechanism for the AR-AF1 upon TFIIF binding (26, 27) and for the GR-AF1 upon interaction with the TATA-binding protein (TBP) (28) and an overall increase in -helical content for both of the otherwise unstructured transactivation domains has been observed.”
BackgroundResultSelf-citationMeimetis, L. G., Williams, D. E., Mawji, N. R., Banuelos, C. A., Lal, A., Park, J. J., Tien, A. H., Fernandez, J. G., de Voogd, N. J., Sadar, M. D., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2014056 · Cited by 75
Davies, P., Watt, K., Kelly, S. M., Clark, C., Price, N. C., & McEwan, I. J. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0042 · Cited by 84
“The AF1 domain is structurally flexible and has the propensity to form a-helix structure (Reid et al. 2002, Kumar et al. 2004a).”
BackgroundSelf-citationKumar, R., & Litwack, G. (2009) · Steroids · doi:10.1016/j.steroids.2009.07.012 · Cited by 79
Targeting molecular resistance in castration-resistant prostate cancer
Chandrasekar, T., Yang, J. C., Gao, A. C., & Evans, C. P. (2015) · BMC Medicine · doi:10.1186/s12916-015-0457-6 · Cited by 72
“Another important target is the NTD of the AR, which has less than 15 % homology with the NTD of other steroid receptors [96–98] and is important for transactivation.”
BackgroundOverview of the structural basis for transcription regulation by nuclear hormone receptors
Kumar, R., Johnson, B. H., & Thompson, E. B. (2004) · Essays in Biochemistry · doi:10.1042/bse0400027 · Cited by 65
“Exposing purified recombinant AF1 protein to the osmolyte trimethylamine N-oxide (TMAO) results in the domain folding co-operatively into a three-dimensional structure [5,6].”
Brodie, J., & McEwan, I. J. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01723 · Cited by 65
Self-citationReid, J., Murray, I., Watt, K., Betney, R., & McEwan, I. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205220200 · Cited by 64
Self-citationPhenotypic plasticity in prostate cancer: role of intrinsically disordered proteins
Mooney, S. M., Jolly, M. K., Levine, H., & Kulkarni, P. (2016) · Asian Journal of Andrology · doi:10.4103/1008-682x.183570 · Cited by 62
Folding of the glucocorticoid receptor N-terminal transactivation function: Dynamics and regulation
Kumar, P., & Thompson, E. B. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.03.024 · Cited by 55
“…2004; Tompa, 2003; Dyson and Wright, 2002; Namba, 2001; Tompa and Fuxreiter, 2008; Crivici and Ikura, 1995; Romero et al., 2004; Warnmark et al., 2001; Reid et al., 2002; Bain et al., 2000; McEwan et al., 1996; Shen et al., 1996; Uversky et al., 2000; Kriwacki et al., 1996; Sartorius et al., 1994).”
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
Estébanez‐Perpiñá, E., Bevan, C. L., & McEwan, I. J. (2021) · Cancers · doi:10.3390/cancers13030509 · Cited by 57
Self-citationLavery, D. N., & McEwan, I. J. (2008) · Biochemistry · doi:10.1021/bi702220p · Cited by 50
Self-citationWardell, S. E., Kwok, S. C., Sherman, L., Hodges, R. S., & Edwards, D. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.8792-8808.2005 · Cited by 48
Nuclear and extranuclear effects of vitamin A
Iskakova, M., Karbyshev, M. S., Piskunov, A., & Rochette‐Egly, C. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0522 · Cited by 48
The Androgen Receptor: Unlocking the Secrets of Its Unique Transactivation Domain
Shen, H. C., & Coetzee, G. A. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71010-4 · Cited by 50
Li, W., Cavasotto, C. N., Cardozo, T. J., Ha, S., Dang, T., Taneja, S. S., Logan, S. K., & Garabedian, M. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0134 · Cited by 50
Androgen Physiology: Receptor and Metabolic Disorders
McEwan, I. J., & Brinkmann, A. O. (2016) · Cited by 46
Self-citationKhan, S. H., Ling, J., & Kumar, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021939 · Cited by 36
“molecules [17], [19], [26], [27], [28], [29], [48], [49], [50], [51], [52], [53], [54], [55], [56].”
BackgroundLavery, D. N., & McEwan, I. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341054 · Cited by 36
Self-citationSakkiah, S., Ng, H. W., Tong, W., & Hong, H. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1192131 · Cited by 36
“of specific protein–protein interactions [44,45].”
Role of conserved hydrophobic amino acids in androgen receptor AF-1 function
Betney, R., & McEwan, I. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310427 · Cited by 33
“However, protein–protein binding studies with this polypeptide suggested that residues 244, 246 and 248 are involved in binding RAP74, the large subunit of TFIIF.”
BackgroundMethodSelf-citationAllosteric pathways in nuclear receptors — Potential targets for drug design
Fernandez, E. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.014 · Cited by 36
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer
Asangani, I. A., Blair, I. A., Duyne, G. D. V., Hilser, V. J., Moiseenkova‐Bell, V. Y., Plymate, S. R., Sprenger, C. C. T., Wand, A. J., & Penning, T. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.012411 · Cited by 35
Wang, G., & Sadar, M. D. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20802 · Cited by 33
“PSA is an example of an androgen-regulated gene with several well-characterized androgen response elements (AREs) to which the AR binds to initiate transcription [Riegman et al., 1991; Cleutjens et al., 1996; Schuur et al., 1996].”
BackgroundLagarde, W. H., Blackwelder, A. J., Minges, J. T., Hnat, A. T., French, F. S., & Wilson, E. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336081 · Cited by 31
“The relative lack of reported missense mutations in the AR NH2-terminal transactivation domain that cause AIS can best be explained by the unstructured nature of this region (10).”
BackgroundHACE1: A novel repressor of RAR transcriptional activity
Zhao, J., Zhang, Z., Vucetic, Z., Soprano, K. J., & Soprano, D. R. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22146 · Cited by 29
“The amino terminal regions of several nuclear receptors, including ER and AR, undergo a transition to a proper folded state upon interaction with coregulatory proteins [Warnmark et al., 2001, 2003; Reid et al., 2002].”
BackgroundIsoform‐specific variation in the intrinsic disorder of the ecdysteroid receptor N‐terminal domain
Nocula‐Ługowska, M., Rymarczyk, G., Lisowski, M., & Ożyhar, A. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22342 · Cited by 29
Garza, A. S., Khan, S. H., Moure, C. M., Edwards, D. P., & Kumar, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025875 · Cited by 30
Ghosh, S. K., Patton, J. R., & Spanjaard, R. A. (2012) · Biochemistry · doi:10.1021/bi300602r · Cited by 31
Acetylation of nuclear receptors in health and disease: an update
Ashton, A. W., Dhanjal, H. K., Rossner, B., Mahmood, H., Patel, V. I., Mohammad, N., Lota, M., Shahid, F., Li, Z., Joyce, D. A., et al. (2022) · FEBS Journal · doi:10.1111/febs.16695 · Cited by 27
“Steroid receptors, including ER a [173], AR [174], PGR [175] and GR [176] contain long NTD that are highly dynamic with little or no secondary structural elements.”
BackgroundStreicher, W., Luedeke, M., Azoitei, A., Zengerling, F., Herweg, A., Genze, F., Schrader, M. G., Schrader, A. J., & Cronauer, M. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098566 · Cited by 28
“of the AR-NTD/TAD making it impossible to use a structure based drug design [50].”
MethodTian, H., Mahajan, M., Wong, C., Habeos, I., & Samuels, H. H. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0437 · Cited by 34
Role of Regulatory F-domain in Hepatocyte Nuclear Factor-4α Ligand Specificity
Petrescu, A. D., Hertz, R., Bar‐Tana, J., Schroeder, F., & Kier, A. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m405906200 · Cited by 26
Androgen Receptor Modulators: A Marriage of Chemistry and Biology
McEwan, I. J. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.69 · Cited by 25
Self-citationSplicing Factor Prp8 Interacts With NESAR and Regulates Androgen Receptor in Prostate Cancer Cells
Wang, D., Nguyen, M. M., Masoodi, K. Z., Singh, P., Jing, Y., O’Malley, K. J., Dar, J. A., Dhir, R., & Wang, Z. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1112 · Cited by 21
An imaging agent to detect androgen receptor and its active splice variants in prostate cancer
Imamura, Y., Tien, A. H., Pan, J., Leung, J. K., Banuelos, C. A., Jian, K., Wang, J., Mawji, N. R., Fernandez, F., Lin, K., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87850 · Cited by 26
DNA binding of nuclear hormone receptors influences their structure and function
Thompson, E. B., & Kumar, R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00877-5 · Cited by 21
Pieprzyk, J., Zbela, A., Jakób, M., Ożyhar, A., & Orłowski, M. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.03.010 · Cited by 20
Peng, S., Wang, J., Chen, H., Hu, P., He, X., He, Y., Wang, M., Tang, W., He, Q.-R., Wang, Y., et al. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09511-x · Cited by 22
Belorusova, A. Y., Ősz, J., Petoukhov, M. V., Peluso‐Iltis, C., Kieffer, B., Svergun, D. I., & Rochel, N. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01122 · Cited by 22
“The HsRXRα DBD (130-212) was expressed in fusion with Thioredoxine and hexahistidine tags in E. coli BL21DE3.”
InfluentialIntrinsic disorder of Drosophila melanogaster hormone receptor 38 N‐terminal domain
Dziedzic‐Letka, A., Rymarczyk, G., Kapłon, T. M., Górecki, A., Szamborska‐Gbur, A., Wojtas, M., Dobryszycki, P., & Ożyhar, A. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22887 · Cited by 19
The Role of the General Transcription Factor IIF in Androgen Receptor-Dependent Transcription
Choudhry, M. A., Ball, A., & McEwan, I. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0486 · Cited by 22
Self-citationComuzzi, B., & Sadar, M. D. (2006) · PubMed · doi:10.1901/jaba.2006.3-61 · Cited by 25
“The AR NTD which is a major therapeutic target [11,47] has been reported to not be folded correctly in vitro thereby raising the possibility for aberrant interactions to occur [48].”
BackgroundTreatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer
Tien, A. H., & Sadar, M. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031817 · Cited by 20
“The AR-NTD is predominantly intrinsically disordered, with approximately 13% helical secondary structure, and this helical content may increase upon binding to interacting proteins [21,22].”
BackgroundDar, J. A., Masoodi, K. Z., Eisermann, K., Isharwal, S., Ai, J., Pascal, L. E., Nelson, J. B., & Wang, Z. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.03.004 · Cited by 18
“AR transactivational activity is primarily mediated through the NTD region containing the activation function 1 (AF1) element, which distinguishes AR from the other steroid receptors that utilize the AF2 region in the LBD (16).”
BackgroundChennakesavalu, S., & Rotskoff, G. M. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c08195 · Cited by 15
“AR is a transcription factor that contains folded DNA and ligand-binding domains and an intrinsically disordered N-terminal transactivation domain (NTD) [62, 42].”
BackgroundTadokoro‐Cuccaro, R., Davies, J., Mongan, N. P., Bunch, T., Brown, R. S., Audí, L., Watt, K., McEwan, I. J., & Hughes, I. A. (2014) · Sexual Development · doi:10.1159/000369266 · Cited by 19
“Different response elements have previously been shown to influence AR activity [Reid et al., 2001].”
BackgroundSelf-citationDuff, J., Davies, P., Watt, K., & McEwan, I. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341098 · Cited by 14
Self-citationCurrent and emerging approaches to noncompetitive AR inhibition
Riley, C. M., Elwood, J. M., Henry, M. C., Hunter, I., Lopez‐Fernandez, J. D., McEwan, I. J., & Jamieson, C. (2023) · Medicinal Research Reviews · doi:10.1002/med.21961 · Cited by 14
“such as enzalutamide (nonsteroidal) and abiraterone (steroidal), the patient outlook has improved, with a 15% increase in 5‐year overall survival.(9) Nevertheless, the prognosis for CRPC remains poor and the need for continued”
BackgroundSelf-citationYi, Q., Han, X., Yu, H. G., Chen, H.-Y., Qiu, D., Su, J., Lin, R., Batist, G., & Wu, J. H. (2024) · Oncogene · doi:10.1038/s41388-024-02944-2 · Cited by 14
“Excitation at 280 nm yield a spectrum that is characterized by emission λ max at ~300 nm due to tryptophans [38], which allowed the structural change of AR-NTD being studied using steady-state fl uorescence emission spectroscopy.”
Local protein unfolding and pathogenesis of polyglutamine‐expansion diseases
Chen, Y. W. (2003) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10325 · Cited by 12
Xue, L., Yu, X., Zhao, L., Garrett, A., Wu, D., & Liu, H. Y. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00743 · Cited by 14
TMAO to the rescue of pathogenic protein variants
Kumari, K., Singh, K. S., Singh, K., Bakhshi, R., & Singh, L. R. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130214 · Cited by 11
Więch, A., Rowińska‐Żyrek, M., Wątły, J., Czarnota, A., Hołubowicz, R., Szewczuk, Z., Ożyhar, A., & Orłowski, M. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.09.008 · Cited by 9
IDPs and their complexes in GPCR and nuclear receptor signaling
Guillien, M., le Maire, A., Mouhand, A., Bernadó, P., Bourguet, W., Banères, J., & Sibille, N. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.05.001 · Cited by 12
A Novel Tandem-Tag Purification Strategy for Challenging Disordered Proteins
Mészáros, A., Muwonge, K., Janvier, S., Ahmed, J., & Tompa, P. (2022) · Biomolecules · doi:10.3390/biom12111566 · Cited by 10
“The existing purification strategy of AF1 recombinant pro‐ tein is based on a single HisTrap via a 6xHis‐tag followed by a SEC polishing step [53].”
MethodTran, T. T., Song, C.-H., Kim, K.-J., & Lee, K. (2020) · American Journal of Cancer Research · Cited by 11
Więch, A., Tarczewska, A., Ożyhar, A., & Orłowski, M. (2021) · Cells · doi:10.3390/cells10030571 · Cited by 8
Synthesis and Evaluation of Small Molecule Inhibitors of the Androgen Receptor N-Terminal Domain
Henry, M. C., Riley, C. M., Hunter, I., Elwood, J. M. L., Lopez‐Fernandez, J. D., Minty, L., Coe, D. M., McEwan, I. J., & Jamieson, C. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00426 · Cited by 8
Self-citationAndrogen receptor nucleocytoplasmic trafficking – A one-way journey
Cole, R. N., Fang, Q., & Wang, Z. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112009 · Cited by 8
Chen, F., Chen, X., Jiang, F., Leng, F., Liu, W. Y., Gui, Y., & Yu, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-68731-7 · Cited by 10
Metadata
- Authors
- Reid, J., Kelly, S. M., Watt, K., Price, N. C., & McEwan, I. J.
- Affiliations
- University of Aberdeen (GB)
- University of Glasgow (GB)
- Corresponding author
- McEwan, Iain J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 277
- Issue
- 22
- Pages
- 20079-20086
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2133833261
- Cited by
- 143
- References
- 56
- Citations by year
- 2025: 2 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 4 · 2020: 8 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 5 · 2013: 6 · 2012: 3
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6728 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Michigan State University
- University of Aberdeen
- Directorate for Biological Sciences
- College of Engineering, Michigan State University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- androgen receptor, N-terminal domain, transactivation domain, protein folding, conformational analysis, alpha-helical structure, trimethylamine N-oxide, trifluoroethanol, osmolytes, RAP74, TFIIF, general transcription factors, protease resistance, nuclear receptor superfamily
- MeSH terms
- Circular Dichroism, Glutathione Transferase, Humans, Ligands, Methylamines, Protein Binding, Protein Conformation, Receptors, Androgen, Spectrometry, Fluorescence, Trypsin, Tryptophan, Transcriptional Activation, Mutagenesis, Site-Directed, Protein Structure, Tertiary, Protein Folding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.